Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals
Shira Perez, Antony Kaspi, Tom Domovitz, et al.
PLoS Genetics (2019) Vol. 15, Iss. 6, pp. e1008181-e1008181
Open Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen, Émilie Crouchet, Thomas F. Baumert
Cells (2020) Vol. 9, Iss. 4, pp. 875-875
Open Access | Times Cited: 862
Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19
Michael J. Corley, Alina P.S. Pang, Kush Dody, et al.
Journal of Leukocyte Biology (2021) Vol. 110, Iss. 1, pp. 21-26
Open Access | Times Cited: 115
<p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>
Srikanta Dash, Yücel Aydın, Kyle E Widmer, et al.
Journal of Hepatocellular Carcinoma (2020) Vol. Volume 7, pp. 45-76
Open Access | Times Cited: 93
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
Ming‐Lung Yu, Pei‐Jer Chen, Chia‐Yen Dai, et al.
Journal of the Formosan Medical Association (2020) Vol. 119, Iss. 7, pp. 1135-1157
Open Access | Times Cited: 86
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
Frank Jühling, Nourdine Hamdane, Émilie Crouchet, et al.
Gut (2020) Vol. 70, Iss. 1, pp. 157-169
Open Access | Times Cited: 81
Hepatitis C Virus and Hepatocellular Carcinoma: When the Host Loses Its Grip
Kaku Goto, Armando Andres Roca Suarez, Florian Wrensch, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3057-3057
Open Access | Times Cited: 79
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population
Ming‐Lung Yu, Pei‐Jer Chen, Chia‐Yen Dai, et al.
Journal of the Formosan Medical Association (2020) Vol. 119, Iss. 6, pp. 1019-1040
Open Access | Times Cited: 74
A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection
Samaa T. Gobran, Petronela Ancuța, Naglaa H. Shoukry
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 65
Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
Pin Zhao, Samiullah Malik, Shaojun Xing
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 60
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan
Pei‐Chien Tsai, Hsing‐Tao Kuo, Chao–Hung Hung, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 281-292
Closed Access | Times Cited: 55
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 1, pp. 219-236
Open Access | Times Cited: 39
Single-cell atlas of the liver myeloid compartment before and after cure of chronic viral hepatitis
Ang Cui, Bo Li, Michael S. Wallace, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 251-267
Closed Access | Times Cited: 25
Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
Felix Fiehn, Claudia Beisel, Marco Binder
Current Opinion in Virology (2024) Vol. 67, pp. 101423-101423
Open Access | Times Cited: 9
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
Luca Rinaldi, Riccardo Nevola, Gianluigi Franci, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1351-1351
Open Access | Times Cited: 69
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
Chung‐Feng Huang, Ming‐Lung Yu
Clinical and Molecular Hepatology (2020) Vol. 26, Iss. 3, pp. 251-260
Open Access | Times Cited: 53
Role of Virus-Induced Host Cell Epigenetic Changes in Cancer
Valeria Pietropaolo, Carla Prezioso, Ugo Moens
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8346-8346
Open Access | Times Cited: 50
A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma
Tommaso Stroffolini, Giacomo Stroffolini
Cancers (2023) Vol. 15, Iss. 8, pp. 2388-2388
Open Access | Times Cited: 21
Residual risk of liver disease after hepatitis C virus eradication
Francesco Negro
Journal of Hepatology (2020) Vol. 74, Iss. 4, pp. 952-963
Open Access | Times Cited: 40
Risk of hepatocellular carcinoma after hepatitis C virus cure
Maria Alejandra Luna‐Cuadros, Hao‐Wei Chen, Hira Hanif, et al.
World Journal of Gastroenterology (2021) Vol. 28, Iss. 1, pp. 96-107
Open Access | Times Cited: 40
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective
Yasser Fouad, Jeffrey V. Lazarus, Francesco Negro, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 53, Iss. 10, pp. 1080-1089
Open Access | Times Cited: 33
Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment
Shinya Maekawa, Shinichi Takano, Nobuyuki Enomoto
Journal of the Formosan Medical Association (2024)
Open Access | Times Cited: 6
Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung‐Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 326-344
Open Access | Times Cited: 6
Epigenetic scars in regulatory T cells are retained after successful treatment of chronic hepatitis C with direct-acting antivirals
So Young Kim, June‐Young Koh, Dong Hyeon Lee, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 5
Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer Progression
Yücel Aydın, Ramazan Kurt, Kyoungsub Song, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1407-1407
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top